
Neurosoft Bioelectronics
Switzerland · MedTech & devices · Seed

Legit.Health
Spain · HealthTech · Seed
Compatibility /100
55/100
High potentialWhy talk
- Both at Seed: peers facing the same fundraising questions right now.
- Complementary sectors: MedTech & devices × HealthTech — room for a joint offer or co-selling.
- Neurosoft Bioelectronics likely needs first paying customers — Legit.Health (Spain, Seed, $5.7M raised, strong traction) can offer access to its customer base (inferred from public profile).
Score anatomy
Each segment is what one dimension adds, out of 100.
Score by goal
Dimension by dimension
Needs ↔ offers
12.3 / 35 pts
Legit.Health can help Neurosoft Bioelectronics.
- Neurosoft Bioelectronics likely needs first paying customers — Legit.Health (Spain, Seed, $5.7M raised, strong traction) can offer access to its customer base (inferred from public profile).
Market bridge
5.0 / 10 pts
Regional bridge.
- Legit.Health (Spain) is a regional neighbour in Europe — a natural first step for cross-border expansion.
Customer potential
4.3 / 5 pts
Strong customer or channel potential.
- Legit.Health has strong traction in a related sector (HealthTech): CE-marked medical device (ISO 13485), with partners listed such as NHS, SERMAS, SESPA, Sanitas, Adeslas, Novartis and Almirall — a proven go-to-market and customer relationships Neurosoft Bioelectronics can learn from or tap.
Sector synergy
12.8 / 15 pts
Complementary sectors.
- Complementary sectors: MedTech & devices × HealthTech — room for a joint offer or co-selling.
Stage complementarity
21.0 / 35 pts
Useful peer or mentor link.
- Both at Seed: peers facing the same fundraising questions right now.
How the score works
Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “Investment”: Needs ↔ offers 35, Market bridge 10, Customer potential 5, Sector synergy 15, Stage complementarity 35. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.
Potential blends compatibility (65%) with the mean global score of both startups (35%): 54/100 — high from 50, medium from 36.